Bourla: Pfizer Will Apply For COVID-19 Vaccine EUA In Late November

Pfizer will apply for emergency use authorization for its COVID-19 vaccine around the third week of November, assuming it gets a positive data readout on efficacy and safety by then, company CEO Albert Bourla says in a Friday (Oct. 16) open letter. The November timeline, which is weeks later than Bourla’s original end-of-October estimate, is based off when Pfizer expects to meet the two-month follow-up up safety data requirement that FDA laid out in guidance this month . Bourla also...